Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread
Open Access
- 1 July 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (7) , 3998-4004
- https://doi.org/10.1128/iai.68.7.3998-4004.2000
Abstract
Pseudomonas aeruginosa is the nosocomial bacterial pathogen most commonly isolated from the respiratory tract. Animal models of this infection are extremely valuable for studies of virulence and immunity. We thus evaluated the utility of a simple model of acute pneumonia for analyzing P. aeruginosa virulence by characterizing the course of bacterial infection in BALB/c mice following application of bacteria to the nares of anesthetized animals. Bacterial aspiration into the lungs was rapid, and 67 to 100% of the inoculum could be recovered within minutes from the lungs, with 0.1 to 1% of the inoculum found intracellularly shortly after infection. At later time points up to 10% of the bacteria were intracellular, as revealed by gentamicin exclusion assays on single-cell suspensions of infected lungs. Expression of exoenzyme U (ExoU) by P. aeruginosa is associated with a cytotoxic effect on epithelial cells in vitro and virulence in animal models. Insertional mutations in the exoU gene confer a noncytotoxic phenotype on mutant strains and decrease virulence for animals. We used the model of acute pneumonia to determine whether introduction of the exoU gene into noncytotoxic strains of P. aeruginosa lacking this gene affected virulence. Seven phenotypically noncytotoxic P. aeruginosa strains were transformed with pUCP19 exoUspcU which carries the exoU gene and its associated chaperone. Three of these strains became cytotoxic to cultured epithelial cells in vitro. These strains all secreted ExoU, as confirmed by detection of the ExoU protein with specific antisera. The 50% lethal dose of exoU -expressing strains was significantly lower for all three P. aeruginosa isolates carrying plasmid pUCP19 exoUspcU than for the isogenic exoU -negative strains. mRNA specific for ExoU was readily detected in the lungs of animals infected with the transformed P. aeruginosa strains. Introduction of the exoU gene confers a cytotoxic phenotype on some, but not all, otherwise-noncytotoxic P. aeruginosa strains and, for recombinant strains that could express ExoU, there was markedly increased virulence in a murine model of acute pneumonia and systemic spread.Keywords
This publication has 21 references indexed in Scilit:
- Penetration of Clinical Isolates ofPseudomonas aeruginosathrough MDCK Epithelial Cell MonolayersThe Journal of Infectious Diseases, 2000
- Pathogenesis of septic shock in Pseudomonas aeruginosa pneumoniaJournal of Clinical Investigation, 1999
- Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.1999
- ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injuryMolecular Microbiology, 1997
- Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathwayMolecular Microbiology, 1996
- Reactive oxygen species in the killing of Pseudomonas aeruginosa by human leukocytesCurrent Microbiology, 1995
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991
- Role of exoenzyme S in chronicPseudomonas aeruginosa lung infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Chapter IV Serological Characterization of Pseudomonas aeruginosaPublished by Elsevier ,1978